Flash Therapeutics is a new gene therapy company developing gene and cell-based therapies by leveraging its proprietary lentiviral platform.
Flash Therapeutics has raised €15M across 1 funding round from 2 investors, most recently a round in Sep 2021. Based in Toulouse, France; active in Healthtech. Data as of 6 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-09-07 | Other |
| €15M |
| Elaia Partners,TechLife Capital |
| View deal → |
